•Impact of Upper Gastrointestinal Involvement on Clinical Outcomes in Paediatric Inflammatory Bowel Disease
•Glucose-derived ultra-small carbon nanozymes for treating inflammatory bowel disease
•Hemophagocytic Lymphohistiocytosis Triggered by HSV-1 in a Patient with Refractory Crohn's Disease After Long-Term Sequential Immunosuppressive Therapy
•JAK1-preferential inhibition in refractory inflammatory bowel disease: reframing upadacitinib as a strategy for rapid immune recalibration
•Who Still Needs Surgery? Defining the Modern Surgical Phenotype in Inflammatory Bowel Disease
